Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Plasma Amylin Concentration With Alzheimer Disease and Brain Structure in Older Adults
Haihao Zhu, Qiushan Tao, Ting Fang Alvin Ang, et al.
JAMA Network Open (2019) Vol. 2, Iss. 8, pp. e199826-e199826
Open Access | Times Cited: 22

Showing 22 citing articles:

Dietary Supplementation with Curcumin Reduce Circulating Levels of Glycogen Synthase Kinase-3β and Islet Amyloid Polypeptide in Adults with High Risk of Type 2 Diabetes and Alzheimer’s Disease
Rohith N. Thota, Jessica I. Rosato, Cintia B. Dias, et al.
Nutrients (2020) Vol. 12, Iss. 4, pp. 1032-1032
Open Access | Times Cited: 89
Cognitive disorder and dementia in type 2 diabetes mellitus
Genaro Gabriel Ortíz, Miguel Huerta, Héctor González-Usigli, et al.
World Journal of Diabetes (2022) Vol. 13, Iss. 4, pp. 319-337
Open Access | Times Cited: 56
Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity
Stjepan Eržen, Gašper Tonin, Dubravka Jurišić‐Eržen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1517-1517
Open Access | Times Cited: 13
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts
Patrick W. Cullinane, Eduardo De Pablo‐Fernández, Annekatrin König, et al.
Movement Disorders (2022) Vol. 38, Iss. 2, pp. 162-177
Closed Access | Times Cited: 33
Aβ efflux impairment and inflammation linked to cerebrovascular accumulation of amyloid-forming amylin secreted from pancreas
Nirmal Verma, Gopal V. Velmurugan, Edric Winford, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 13
The association of circulating amylin with β‐amyloid in familial Alzheimer's disease
Han Ly, Nirmal Verma, Savita Sharma, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 31
Peripheral insulin and amylin levels in Parkinson's disease
Almudena Sánchez‐Gómez, Gema Alcarraz‐Vizán, Manel Fernández, et al.
Parkinsonism & Related Disorders (2020) Vol. 79, pp. 91-96
Closed Access | Times Cited: 30
Multiscale Modeling of Macromolecular Interactions between Tau-Amylin Oligomers and Asymmetric Lipid Nanodomains That Link Alzheimer’s and Diabetic Diseases
Natália Quevedo dos Santos, Luthary Segura, Amber Lewis, et al.
Molecules (2024) Vol. 29, Iss. 3, pp. 740-740
Open Access | Times Cited: 3
Exploring Tau Fibril-Disaggregating and Antioxidating Molecules Binding to Membrane-Bound Amyloid Oligomers Using Machine Learning-Enhanced Docking and Molecular Dynamics
Luthary Segura, Natália Quevedo dos Santos, Rafael Flores, et al.
Molecules (2024) Vol. 29, Iss. 12, pp. 2818-2818
Open Access | Times Cited: 3
Structural Analysis of Amylin and Amyloid β Peptide Signaling in Alzheimer’s Disease
Lisi Xie, Christopher Lockhart, Steven R. Bowers, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 89-89
Open Access
Novel strategies for targeting tau oligomers in neurodegenerative diseases
Jing Lin, Haipeng Li, Lingling Jiang, et al.
Journal of Neurology (2025) Vol. 272, Iss. 6
Closed Access
Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in a Transgenic Rat Model of Type 2 Diabetes
Ling Wu, Paul Velander, Anne M. Brown, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 4, pp. 1322-1337
Open Access | Times Cited: 15
Rapid, scalable assay of amylin-β amyloid co-aggregation in brain tissue and blood
Deepak Kotiya, Noah S Leibold, Nirmal Verma, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 5, pp. 104682-104682
Open Access | Times Cited: 6
Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer’s Disease
Rachel Corrigan, Luis Labrador, John Grizzanti, et al.
Journal of Alzheimer s Disease (2023) Vol. 91, Iss. 4, pp. 1495-1514
Closed Access | Times Cited: 5
Type‐2 Diabetes, Pancreatic Amylin, and Neuronal Metabolic Remodeling in Alzheimer's Disease
Noah S Leibold, James R. Bain, Florin Despa
Molecular Nutrition & Food Research (2023) Vol. 68, Iss. 13
Open Access | Times Cited: 4
Exploring the Role of Anionic Lipid Nanodomains in the Membrane Disruption and Protein Folding of Human Islet Amyloid Polypeptide Oligomers on Lipid Membrane Surfaces Using Multiscale Molecular Dynamics Simulations
Ngoc Thanh Nguyên, Amber Lewis, Thuong Pham, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4191-4191
Open Access | Times Cited: 4
The human islet amyloid polypeptide reduces hippocampal tauopathy and behavioral impairments in P301S mice without inducing neurotoxicity or seeding amyloid aggregation
Ying-Ying Yang, Yan-Tao Ren, Meng‐Yu Jia, et al.
Experimental Neurology (2023) Vol. 362, pp. 114346-114346
Closed Access | Times Cited: 3
Novel Hominid-Specific IAPP Isoforms: Potential Biomarkers of Early Alzheimer’s Disease and Inhibitors of Amyloid Formation
Qing‐Rong Liu, Min Zhu, Qinghua Chen, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 167-167
Open Access | Times Cited: 2
Amylin Pharmacology in Alzheimer’s Disease Pathogenesis and Treatment
Gemma Casadesús, Rachel R. Corrigan, Helen Piontkivska
Current Neuropharmacology (2021) Vol. 20, Iss. 10, pp. 1894-1907
Open Access | Times Cited: 5
Insulin resistance, diabetes and Parkinson's disease: The match continues
Anna Delamarre, Vincent Rigalleau, Wassilios G. Meissner
Parkinsonism & Related Disorders (2020) Vol. 80, pp. 199-200
Closed Access | Times Cited: 4
Novel Amylin Analogues Reduce Amyloid-β Cross-Seeding Aggregation and Neurotoxicity
Gowdame Lakshmanan Dharmaraj, Fraulein Denise Arigo, Kimberly A. Young, et al.
Journal of Alzheimer s Disease (2022) Vol. 87, Iss. 1, pp. 373-390
Closed Access | Times Cited: 3
Molecular Mechanisms of Protein–Lipid Interactions and Protein Folding of Heterogeneous Amylin and Tau Oligomers on Lipid Nanodomains That Link to Alzheimer’s
Natália Quevedo dos Santos, Luthary Segura, Amber Lewis, et al.
Macromol—A Journal of Macromolecular Research (2023) Vol. 3, Iss. 4, pp. 805-827
Open Access | Times Cited: 1
Catechol-Containing Compounds are a Broad Class of Protein Aggregation Inhibitors: II. Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in HIP Rats
Ling Wu, Paul Velander, Anne M. Brown, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 2
Page 1

Scroll to top